scispace - formally typeset
A

Aneesa Sultan

Researcher at Quaid-i-Azam University

Publications -  35
Citations -  1625

Aneesa Sultan is an academic researcher from Quaid-i-Azam University. The author has contributed to research in topics: Oxidative stress & Cell polarity. The author has an hindex of 11, co-authored 34 publications receiving 1455 citations. Previous affiliations of Aneesa Sultan include Max F. Perutz Laboratories.

Papers
More filters
Journal ArticleDOI

The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

TL;DR: The data show that ZEB1 represents a key player in pathologic EMTs associated with tumour progression, and downregulation in undifferentiated cancer cells by RNA interference was sufficient to upregulate expression of cell polarity genes on the RNA and protein level, to re-establish epithelial features and to impair cell motility in vitro.
Journal ArticleDOI

The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer

TL;DR: It is described that the EMT-inducing transcriptional repressor ZEB1 promotes colorectal cancer cell metastasis and loss of cell polarity and shows that retention of Lgl2 expression is critical for the epithelial phenotype and that its loss might be involved in metastasis.
Journal ArticleDOI

Role of nutrients in bacterial biosurfactant production and effect of biosurfactant production on petroleum hydrocarbon biodegradation

TL;DR: It is concluded that biosurfactant production is influenced by the availability of nutrients, which can be enhanced with the use of biosurFactant producing bacteria.
Journal ArticleDOI

Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery

TL;DR: A deeper understanding of ovarian cancer-derived EVs, the types of cargo molecules and their biological roles in cancer growth, metastases and drug resistance, could have significant impact on the discovery of novel biomarkers and innovative therapeutics.